mTOR in Viral Hepatitis and Hepatocellular Carcinoma: Function and Treatment
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
mTOR in Viral Hepatitis and Hepatocellular Carcinoma: Function and Treatment
Authors
Keywords
-
Journal
Biomed Research International
Volume 2014, Issue -, Pages 1-9
Publisher
Hindawi Limited
Online
2014-04-03
DOI
10.1155/2014/735672
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates
- (2013) R. K. Kelley et al. ANNALS OF ONCOLOGY
- Phase I study investigating everolimus combined with sorafenib in patients with advanced hepatocellular carcinoma
- (2013) Richard S. Finn et al. JOURNAL OF HEPATOLOGY
- Randomised clinical trial: comparison of two everolimus dosing schedules in patients with advanced hepatocellular carcinoma
- (2012) H.-S. Shiah et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Glutamine stimulates mTORC1 independent of the cell content of essential amino acids
- (2012) Martina Chiu et al. AMINO ACIDS
- Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblastine combination in hepatocellular carcinoma
- (2012) Qian Zhou et al. BIOCHEMICAL PHARMACOLOGY
- Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model
- (2012) Cun Wang et al. BMC CANCER
- PKM2 Phosphorylates Histone H3 and Promotes Gene Transcription and Tumorigenesis
- (2012) Weiwei Yang et al. CELL
- V-AKT murine thymoma viral oncogene homolog/mammalian target of rapamycin activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis
- (2012) Matthias Evert et al. HEPATOLOGY
- Hepatitis C Virus Upregulates Beclin1 for Induction of Autophagy and Activates mTOR Signaling
- (2012) Shubham Shrivastava et al. JOURNAL OF VIROLOGY
- HBx induces HepG-2 cells autophagy through PI3K/Akt–mTOR pathway
- (2012) Peng Wang et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Glutaminolysis Activates Rag-mTORC1 Signaling
- (2012) Raúl V. Durán et al. MOLECULAR CELL
- Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer
- (2012) Barbara Chaneton et al. TRENDS IN BIOCHEMICAL SCIENCES
- Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
- (2011) Weibo Luo et al. CELL
- Novel feedback inhibition of surface antigen synthesis by mammalian target of rapamycin (mTOR) signal and its implication for hepatitis B virus tumorigenesis and therapy
- (2011) Chiao-Fang Teng et al. HEPATOLOGY
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Growth inhibition by NVP-BEZ235, a dual PI3K/mTOR inhibitor, in hepatocellular carcinoma cell lines
- (2011) Tetsuya Nakatsura ONCOLOGY REPORTS
- Synergistic effect of mTOR inhibitor rapamycin and fluorouracil in inducing apoptosis and cell senescence in hepatocarcinoma cells
- (2010) Xinxin Bu et al. CANCER BIOLOGY & THERAPY
- Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4E
- (2010) Andrew C. Hsieh et al. CANCER CELL
- Increased Lipogenesis, Induced by AKT-mTORC1-RPS6 Signaling, Promotes Development of Human Hepatocellular Carcinoma
- (2010) Diego F. Calvisi et al. GASTROENTEROLOGY
- Q39, a quinoxaline 1,4-Di-N-oxide derivative, inhibits hypoxia-inducible factor-1α expression and the Akt/mTOR/4E-BP1 signaling pathway in human hepatoma cells
- (2010) Qinjie Weng et al. INVESTIGATIONAL NEW DRUGS
- Hepatitis C Virus NS5A Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Contributing to Cell Survival by Disrupting the Interaction between FK506-binding Protein 38 (FKBP38) and mTOR
- (2010) Lu Peng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mechanisms of HBV-related hepatocarcinogenesis
- (2010) Christine Neuveut et al. JOURNAL OF HEPATOLOGY
- Structure of the Human mTOR Complex I and Its Implications for Rapamycin Inhibition
- (2010) Calvin K. Yip et al. MOLECULAR CELL
- Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1
- (2010) Katrin Düvel et al. MOLECULAR CELL
- Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and Stress
- (2010) Shomit Sengupta et al. MOLECULAR CELL
- Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis
- (2010) Darcy A. Krueger et al. NEW ENGLAND JOURNAL OF MEDICINE
- mTOR Complex 2 Is Required for the Development of Prostate Cancer Induced by Pten Loss in Mice
- (2009) David A. Guertin et al. CANCER CELL
- Enhanced expression of vascular endothelial growth factor-A in ground glass hepatocytes and its implication in hepatitis B virus hepatocarcinogenesis
- (2009) Jui-Chu Yang et al. HEPATOLOGY
- The mTOR pathway is associated with the poor prognosis of human hepatocellular carcinoma
- (2009) Ledu Zhou et al. MEDICAL ONCOLOGY
- Clinical Trial Experience With Temsirolimus in Patients With Advanced Renal Cell Carcinoma
- (2009) Gary R. Hudes et al. SEMINARS IN ONCOLOGY
- TOR complex 2 is needed for cell cycle progression and anchorage-independent growth of MCF7 and PC3 tumor cells
- (2008) Ville Hietakangas et al. BMC CANCER
- Inhibition of mTOR enhances chemosensitivity in hepatocellular carcinoma
- (2008) Ka Ho Tam et al. CANCER LETTERS
- SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth
- (2008) Thomas Porstmann et al. Cell Metabolism
- Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
- (2008) Augusto Villanueva et al. GASTROENTEROLOGY
- Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer
- (2008) Magnus Rizell et al. International Journal of Clinical Oncology
- Inhibition of mTOR in combination with doxorubicin in an experimental model of hepatocellular carcinoma
- (2008) Anne-Christine Piguet et al. JOURNAL OF HEPATOLOGY
- Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma
- (2008) Hung Huynh et al. JOURNAL OF HEPATOLOGY
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial
- (2008) Robert J Motzer et al. LANCET
- eIF4E knockdown decreases breast cancer cell growth without activating Akt signaling
- (2008) A. Soni et al. MOLECULAR CANCER THERAPEUTICS
- Regulation of TORC1 by Rag GTPases in nutrient response
- (2008) Eunjung Kim et al. NATURE CELL BIOLOGY
- The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1
- (2008) Y. Sancak et al. SCIENCE
- PTEN Down-Regulation by Unsaturated Fatty Acids Triggers Hepatic Steatosis via an NF-κBp65/mTOR-Dependent Mechanism
- (2007) Manlio Vinciguerra et al. GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More